---
# Display name
title: 한승훈, MD, PhD
weight: 5
# Is this the primary user of the site?
superuser: false

# Role/position
role: 부교수

# Organizations/Affiliations
organizations:
- name: 가톨릭의대

# Organizational groups that you belong to (for People widget)
#   Set this to `[]` or comment out if you are not using People widget.
user_groups:
- 교수
---

## 정보

- 소속 : 약리학교실
- 직위 : 부교수
- 전공 : 약리학
- 세부전공 : 임상약리학
- 연락처 : 02 2258 7326
- 이메일 : waystolove@catholic.ac.kr

## 논문
- Usefulness of Bnet, a Simple Linear Metric in Discerning Torsades De Pointes Risks in 28 CiPA Drugs, FRONTIERS IN PHARMACOLOGY, 201911
- Three-Dimensional Heart Model-Based Screening of Proarrhythmic Potential by in silico Simulation of Action Potential and Electrocardiograms, FRONTIERS IN PHYSIOLOGY, 201909
- Quantitative Prediction of Human Pharmacokinetics and Pharmacodynamics of CKD519, a Potent Inhibitor of Cholesteryl Ester Transfer Protein (CETP), PHARMACEUTICS, 201907
- Application of Pharmacometrics in Pharmacotherapy: Open-Source Software for Vancomycin Therapeutic Drug Management, PHARMACEUTICS, 201905
- A Randomized, Double-Blind Trial Comparing the Pharmacokinetics of CT-P16, a Candidate Bevacizumab Biosimilar, with its Reference Product in Healthy Adult Males, BIODRUGS, 201904
- A simplified prognostic model to predict mortality in patients with acute variceal bleeding, DIGESTIVE AND LIVER DISEASE, 201803
- Human microdosing and mice xenograft data of AGM-130 applied to estimate efficacious doses in patients, CANCER CHEMOTHERAPY AND PHARMACOLOGY, 201708
- A 6-month mixed-effect pharmacokinetic model for post-transplant intravenous anti-hepatitis B immunoglobulin prophylaxis, DRUG DESIGN DEVELOPMENT AND THERAPY, 201707
- Bortezomib pharmacokinetics in tumor response and peripheral neuropathy in multiple myeloma patients receiving bortezomib-containing therapy, ANTI-CANCER DRUGS, 201707
- Drug-drug interaction of microdose and regular-dose omeprazole with a CYP2C19 inhibitor and inducer, DRUG DESIGN DEVELOPMENT AND THERAPY, 201705
- Use of a Target-Mediated Drug Disposition Model to Predict the Human Pharmacokinetics and Target Occupancy of GC1118, an Anti-epidermal Growth Factor Receptor Antibody, BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 201703
- Comparison of oral absorption models for pregabalin: usefulness of transit compartment model, DRUG DESIGN DEVELOPMENT AND THERAPY, 201612
- Immunogenicity and safety of trivalent split influenza vaccine in healthy Korean adults with low pre-existing antibody levels: An open phase I trial, YONSEI MEDICAL JOURNAL, 201611
- Therapeutic drug monitoring and safety of intravenous voriconazole formulated with sulfobutylether β-cyclodextrin in haematological patients with renal impairment, MYCOSES, 201610
- Comparative Pharmacokinetic Analysis of Thiamine and Its Phosphorylated Metabolites Administered as Multivitamin Preparations, CLINICAL THERAPEUTICS, 201610
- Tips for the choice of initial estimates in NONMEM, TRANSLATIONAL AND CLINICAL PHARMACOLOGY(구.임상약리학회지), 201609
- Collaborative pharmacokinetic-pharmacodynamic research for optimization of antimicrobial therapy, INFECTION AND CHEMOTHERAPY (구.감염과 화학요법), 201609
- Population pharmacokinetics and inter-laboratory variability of sildenafil and its metabolite after oral administration in Korean healthy male volunteers, TRANSLATIONAL AND CLINICAL PHARMACOLOGY(구.임상약리학회지), 201606
- Population pharmacokinetics of imatinib mesylate in healthy Korean subjects, TRANSLATIONAL AND CLINICAL PHARMACOLOGY(구.임상약리학회지), 201606
- Simulation of PET scan timings for receptor occupancy studies of CNS drugs: a simple fixed-time design performed as well as scattered time point designs, EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 201511
- Model-based adaptive phase I trial design of post-transplant decitabine maintenance in myelodysplastic syndrome, JOURNAL OF HEMATOLOGY & ONCOLOGY, 201510
- Exposure-response model for sibutramine and placebo: suggestion for application to long-term weight-control drug development, DRUG DESIGN DEVELOPMENT AND THERAPY, 201509
- Clinical pharmacology review for primary health care providers: II. Steroids, TRANSLATIONAL AND CLINICAL PHARMACOLOGY(구.임상약리학회지), 201506
- Pharmacokinetic-pharmacodynamic analysis to evaluate the effect of moxifloxacin on QT interval prolongation in healthy Korean male subjects, DRUG DESIGN DEVELOPMENT AND THERAPY, 201502
- Clinical vaccine development, CLINICAL AND EXPERIMENTAL VACCINE RESEARCH, 201501
- Serotonin transporter occupancy of SKL10406 in humans: comparison of pharmacokineticpharmacodynamic modeling methods for estimation of occupancy parameters, 임상약리학회지, 201412
- Population pharmacokinetic and pharmacodynamic modeling of transformed binary effect data of triflusal in healthy Korean male volunteers: a randomized, open-label, multiple dose, crossover study, BMC PHARMACOLOGY & TOXICOLOGY, 201412
- Early non-steady-state population pharmacokinetics of oral cyclosporine in renal transplant recipients, DRUG DESIGN DEVELOPMENT AND THERAPY, 201411
- Population Pharmacokinetic Analysis of Piperacillin in Burn Patients, ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 201407

## 저서

- 계량약리학 워크샵 초급과정, 부크크, 202007
